Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty

PURPOSE: Gonadotropin-releasing hormone agonist (GnRHa) has been the mainstay of central precocious puberty (CPP) treatment for decades, but few reports have compared the efficacy of 1-month and 3-month depot GnRHa formulations. This study investigates the short-term efficacy of 1-month and 3-month...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Min Jin, Choe, Jae Won, Chung, Hye Rim, Kim, Jae Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Pediatric Endocrinology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505044/
https://www.ncbi.nlm.nih.gov/pubmed/34015908
http://dx.doi.org/10.6065/apem.2040134.067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505044/
https://www.ncbi.nlm.nih.gov/pubmed/34015908
http://dx.doi.org/10.6065/apem.2040134.067

Ejemplares similares